Skip to main content
Fig. 5 | Journal of Translational Medicine

Fig. 5

From: A comparative study on ctDNA and tumor DNA mutations in lung cancer and benign cases with a high number of CTCs and CTECs

Fig. 5

Analysis of the plasma cfDNA concentration in enrolled 28 patients. A Plasma cfDNA concentration between patients with or without ctDNA mutations. B  Plasma cfDNA concentration between different TNM stages. C Plasma cfDNA concentration between different pathological types. D Tumor size (Maximum tumor diameter, MTD) between different pathological types. E The correlation between cfDNA concentration and tumor size (MTD). F The correlation between cfDNA concentration and counts of CTCs. G The correlation between cfDNA concentration and counts of CTECs. H The correlation between the concentration of cfDNA and CYFRA 21–1.*P < 0.05, **P < 0.01, ***P < 0.001, ****P < 0.0001, Mann–Whitney U test

Back to article page